This phase 1-2 trial evaluates the use of combination therapy with O6-benzylguanine and carmustine to determine the maximum tolerated dose in patients with stage IA or stage IIA cutaneous T-cell lymphoma, mycosis fungoides type.
http://ift.tt/2lhZtMu
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου